X
FDA approves Ionis/Akcea’s Tegsedi RNAi drug, taking on Alnylam
https://pharmaphorum.com/news/fda-approves-ionis-akceas-tegsedi-competing-against-alnylam/
Alnylam
Alnylam’s Onpattro is first ever FDA-approved RNAi drug
Onpattro will cost $450,000 a year
AZ grabs licence as Ionis NASH drug heads to the clinic
Could antisense drug be a fatty liver disease blockbuster?
1 2
